Positive and negative symptoms in schizophrenia: the NMDA receptor hypofunction hypothesis, neuregulin/ErbB4 and synapse regression

References

• Carlsson A. The neurochemical circuitry of schizophrenia. Pharmacopsychiatry 2006; 39(Suppl 1)S10–S14
   PubMed Web of Science ®Google Scholar
• Carlsson M, Carlsson A. Schizophrenia: a subcortical neurotransmitter imbalance syndrome?. Schizophr Bull 1990; 16: 425–432
   PubMed Web of Science ®Google Scholar
• Bennett MR. Dual constraints on synapse formation and regression in schizophrenia: neuregulin, neuroligin, dysbindin, DISC1, musk and agrin. Aust N Z J Psychiatry 2008; 42: 662–677
   PubMed Web of Science ®Google Scholar
• Bennett MR. Consciousness and hallucinations in schizophrenia: the role of synapse regression. Aust N Z J Psychiatry 2008; 42: 915–931
   PubMed Web of Science ®Google Scholar
• Pollard TD. The cytoskeleton, cellular motility and the reductionist agenda. Nature 2003; 422: 741–745
   PubMed Web of Science ®Google Scholar
• Ali DW, Salter MW. NMDA receptor regulation by Src kinase signalling in excitatory synaptic transmission and plasticity. Curr Opin Neurobiol 2001; 11: 336–342
   PubMed Web of Science ®Google Scholar
• Ethell IM, Pasquale EB. Molecular mechanisms of dendritic spine development and remodeling. Prog Neurobiol 2005; 75: 161–205
   PubMed Web of Science ®Google Scholar
• Gray JA, Roth BL. The pipeline and future of drug development in schizophrenia. Mol Psychiatry 2007; 12: 904–922
   PubMed Web of Science ®Google Scholar
• Schubert V, Dotti CG. Transmitting on actin: synaptic control of dendritic architecture. J Cell Sci 2007; 120(Pt 2)205–212
   PubMed Web of Science ®Google Scholar
• Cingolani LA, Goda Y. Actin in action: the interplay between the actin cytoskeleton and synaptic efficacy. Nat Rev Neurosci 2008; 9: 344–356
   PubMed Web of Science ®Google Scholar
• Saneyoshi T, Wayman G, Fortin D, et al. Activity-dependent synaptogenesis: regulation by a CaM-kinase kinase/CaM-kinase 1/betaPIX signaling complex. Neuron 2008; 57: 94–107
   PubMed Web of Science ®Google Scholar
• Nakayama AY, Luo L. Intracellular signaling pathways that regulate dendritic spine morphogenesis. Hippocampus 2000; 10: 582–586
   PubMed Web of Science ®Google Scholar
• Da Silva JS, Medina M, Zuliani C, Di Nardo A, Witke W, Dotti CG. RhoA/ROCK regulation of neuritogenesis via profilin 11a-mediated control of actin stability. J Cell Biol 2003; 162: 1267–1279
   PubMed Web of Science ®Google Scholar
• Schubert V, Da Silva JS, Dotti CG. Localized recruitment and activation of RhoA underlies dendritic spine morphology in a glutamate receptor-dependent manner. J Cell Biol 2006; 172: 453–467
   PubMed Web of Science ®Google Scholar
• Schmidt JT, Morgan P, Dowell N, Leu B. Myosin light chain phosphorylation and growth cone motility. J Neurobiol 2002; 52: 175–188
   PubMed Web of Science ®Google Scholar
• Zhou W, Carpenter G. Heregulin-dependent translocation and hyperphosphorylation of ErbB-2. Oncogene 2001; 20: 3918–3920
   PubMed Web of Science ®Google Scholar
• Holbro T, Hynes NE. ErbB receptors: directing key signaling networks throughout life. Annu Rev Pharmacol Toxicol 2004; 44: 195–217
   PubMed Web of Science ®Google Scholar
• Qiu C, Tarrant MK, Choi SH, et al. Mechanism of activation and inhibition of the HER4/ErbB4 kinase. Structure 2008; 16: 460–467
   PubMed Web of Science ®Google Scholar
• Zhou W, Carpenter G. Heregulin-dependent trafficking and cleavage of ErbB-4. J Biol Chem 2000; 275: 34 737–34 743
   Web of Science ®Google Scholar
• Chattopadhyay A, Vecchi M, Ji Q, Mernaugh R, Carpenter G. The role of individual SH2 domains in mediating association of phospholipase C-gamma1 with the activated EGF receptor. J Biol Chem 1999; 274: 26 091–26 097
   Web of Science ®Google Scholar
• Schulze WX, Deng L, Mann M. Phosphotyrosine interactome of the ErbB receptor kinase family. Mol Syst Biol 2005; 1: 2005–2008
   PubMed Web of Science ®Google Scholar
• Sweeney C, Lai C, Riese DJ II, Diamonti AJ, Cantley LC, Carraway KL III. Ligand discrimination in signaling through an ErbB4 receptor homodimer. J Biol Chem 2000; 275: 19 803–19 807
   Web of Science ®Google Scholar
• Murphy SP, Bielby-Clarke K. Neuregulin signaling in neurons depends on ErbB4 interaction with PSD-95. Brain Res 2008; 1207: 32–35
   PubMed Web of Science ®Google Scholar
• Garcia RA, Vasudevan K, Buonanno A. The neuregulin receptor ErbB4 interacts with PDZ-containing proteins at neuronal synapses. Proc Natl Acad Sci USA 2000; 97: 3596–3601
   PubMed Web of Science ®Google Scholar
• Huang YZ, Won S, Ali DW, et al. Regulation of neuregulin signaling by PSD-25 interacting with ErbB4 at CNS synapses. Neuron 2000; 26: 443–455
   PubMed Web of Science ®Google Scholar
• Yu XM, Askalan R, Keil GJ II, Salter MW. NMDA channel regulation by channel-associated protein tyrosine kinase Src. Science 1997; 275: 674–678
   PubMed Web of Science ®Google Scholar
• Kalia LV, Gingrich JR, Salter MW. Src in synaptic transmission and plasticity. Oncogene 2004; 23: 8007–8016
   PubMed Web of Science ®Google Scholar
• Wang YT, Salter MW. NMDA receptor regulation by tyrosine kinases and phosphatases. Nature 1994; 369: 233–235
   PubMed Web of Science ®Google Scholar
• Gingrich JR, Pelkey KA, Fam SR, et al. Unique domain anchoring of Src to synaptic NMDA receptors via the mitochondrial protein NADH dehydrogenase subunit 2. Proc Natl Acad Sci USA 2004; 101: 6237–6242
   PubMed Web of Science ®Google Scholar
• Huang Y, Lu W, Ali DW, et al. CAKbeta/Pyk2 kinase is a signaling link for induction of long-term potentiation in CA1 hippocampus. Neuron 2001; 29: 485–496
   PubMed Web of Science ®Google Scholar
• Guo J, Meng F, Fu X, Song B, Yan X, Zhang G. N-methyl-D-aspartate receptor and L-type voltage-gated Ca2+ channel activation mediate proline-rich tyrosine kinase 2 phosphorylation during cerebral ischaemia in rats. Neurosci Lett 2004; 355: 177–180
   PubMed Web of Science ®Google Scholar
• Salter MW, Kalia LV. Src kinases: a hub for NMDA receptor regulation. Nat Rev Neurosci 2004; 5: 317–328
   PubMed Web of Science ®Google Scholar
• Tezuka T, Umemori H, Akiyama T, Nakanishi S, Yamamoto T. PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A. Proc Natl Acad Sci USA 1999; 96: 435–440
   PubMed Web of Science ®Google Scholar
• Cheung HH, Gurd JW. Tyrosine phosphorylation of the N-methyl-D-aspartate receptor by exogenous and postsynaptic density-associated Src-family kinases. J Neurochem 2001; 78: 524–534
   PubMed Web of Science ®Google Scholar
• Rostas JA, Brent VA, Voss K, Errington ML, Bliss TV, Gurd JW. Enhanced tyrosine phosphorylation of the 2B subunit of the N-methyl-D-aspartate receptor in long-term potentiation. Proc Natl Acad Sci USA 1996; 93: 10 452–10 456
   Web of Science ®Google Scholar
• Kojima N, Wang J, Mansuy IM, Grant SG, Mayford M, Kandel ER. Rescuing impairment of long-term potentiation in fyn-deficient mice by introducing Fyn transgene. Proc Natl Acad Sci USA 1997; 94: 4761–4765
   PubMed Web of Science ®Google Scholar
• Bhaskar K, Yen SH, Lee G. Disease-related modifications in tau affect the interaction between Fyn and Tau. J Biol Chem 2005; 280: 35 119–35 125
   Web of Science ®Google Scholar
• Sarnago S, Elorza A, Mayor F, Jr. Agonist-dependent phosphorylation of the G protein-coupled receptor kinase 2 (GRK2) by Src tyrosine kinase. J Biol Chem 1999; 274: 34411–34416
   PubMed Web of Science ®Google Scholar
• Solomaha E, Szeto FJ, Yousef MA, Palfrey HC. Kinetics of Src homology 3 domain association with the proline-rich domain of dynamins: specificity, occlusion, and the effects of phosphorylation. J Biol Chem 2005; 280: 23 147–23 156
   Web of Science ®Google Scholar
• Lu YM, Roder JC, Davidow J, Salter MW. Src activation in the induction of long-term potentiation in CA1 hippocampal neurons. Science 1998; 279: 1363–1367
   PubMed Web of Science ®Google Scholar
• Xu J, Weerapura M, Ali MK, et al. Control of excitatory synaptic transmission by C-terminal Src kinase. J Biol Chem 2008; 283: 17 503–17 514
   Web of Science ®Google Scholar
• Kholodenko BN, Demin OV, Moehren G, Hoek JB. Quantification of short term signaling by the epidermal growth factor receptor. J Biol Chem 1999; 274: 30 169–30 181
   Web of Science ®Google Scholar
• Moehren G, Markevich N, Demin O, et al. Temperature dependence of the epidermal growth factor receptor signaling network can be accounted for by a kinetic model. Biochemistry 2002; 41: 306–320
   PubMed Web of Science ®Google Scholar
• Hatakeyama M, Kimura S, Naka T, et al. A computational model on the modulation of mitogen-activated protein kinase (MAPK) and Akt pathways in heregulin-induced ErbB signalling. Biochem J 2003; 373(Pt 2)451–463
   PubMed Web of Science ®Google Scholar
• Nakakuki T, Yumoto N, Naka T, Shirouzu M, Yokoyama S, Hatakeyama M. Topological analysis of MAPK cascade for kinetic ErbB signaling. PLoS ONE 2008; 3: e1782
   PubMed Web of Science ®Google Scholar
• Schoeberl B, Eichler-Jonsson C, Gilles ED, Müller G. Computational modeling of the dynamics of the MAP kinase activated by surface and internalized EGF receptors. Nat Biotechnol 2002; 20: 370–375
   PubMed Web of Science ®Google Scholar
• Mayadevi M, Praseeda M, Kumar KS, Omkumar RV. Sequence determinants on the NR2A and NR2B subunits of NMDA receptor responsible for specificity of phosphorylation by CaMK11. Biochem Biophys Acta 2002; 15 9840–15 9845
   Web of Science ®Google Scholar
• Castellani GC, Quinlan EM, Bersani F, Cooper LN, Shouval HZ. A model of bidirectional synaptic plasticity: from signaling network to channel conductance. Learn Mem 2005; 12: 423–432
   PubMed Web of Science ®Google Scholar
• Huang YZ, Won S, Ali DW, et al. Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. Neuron 2000; 26: 443–455
   PubMed Web of Science ®Google Scholar
• Ma L, Huang YZ, Pitcher GM, et al. Ligand-dependent recruitment of the ErbB4 signaling complex into neuronal lipid rafts. J. Neurosci 2003; 23: 3164–3175
   Web of Science ®Google Scholar
• Kwon OB, Longart M, Vullhorst D, Hoffman DA, Buonanno A. Neuregulin-1 reverses long-term potentiation at Ca1 hippocampal synapses. J Neuroscience 2005; 25: 9378–9383
   PubMed Web of Science ®Google Scholar
• Gu Z, Jiang Q, Fu AK, Ip NY, Yan Z. Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex. J Neurosci 2005; 25: 4974–4984
   PubMed Web of Science ®Google Scholar
• Roysommuti S, Carroll SL, Wyss JM. Neuregulin-1beta modulates in vivo entorhinal-hippocampal synaptic transmission in adult rats. Neuroscience 2003; 121: 779–785
   PubMed Web of Science ®Google Scholar
• Woo RS, Li XM, Tao Y, et al. Neuregulin-1 enhances depolarization-induced GABA release. Neuron 2007; 54: 599–610
   PubMed Web of Science ®Google Scholar
• Stefansson H, Sigurdsson E, Steinthorsdottir S, et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002; 71: 877–892
   PubMed Web of Science ®Google Scholar
• Li B, Woo RS, Mei L, Malinow R. The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron 2007; 54: 583–597
   PubMed Web of Science ®Google Scholar
• Bjarnadottir M, Misner DL, Haverfield-Gross S, et al. Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1 + /− knock-outs compared with wild-type mice. J Neurosci 2007; 27: 4519–4529
   PubMed Web of Science ®Google Scholar
• Hahn CG, Wang HY, Cho DS, et al. Altered neuregulin 1-ErbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med 2006; 12: 824–828
   PubMed Web of Science ®Google Scholar
• Fischbach GD. Schizophrenia: signals from the other side. Nat Med 2006; 12: 734–735
   PubMed Web of Science ®Google Scholar
• Rio C, Buxbaum JD, Peschon JJ, Corfas G. Tumor necrosis factor-alpha-converting enzyme is required for cleavage of ErbB4/HER4. J Biol Chem 2000; 275: 10 379–10 387
   Web of Science ®Google Scholar
• Ni CY, Murphy MP, Golde TE, Carpenter G. Gamma-secretase cleavage and nuclear localization of ErbB4 receptor tyrosine kinase. Science 2001; 294: 2179–2181
   PubMed Web of Science ®Google Scholar
• Plowman GD, Green JM, Culouscou JM, Cartlon GW, Rothwell VM, Buckley S. Heregulin induces tyrosine phosphorylation of HER4/p180erbB4. Nature 1993; 366: 473–475
   PubMed Web of Science ®Google Scholar
• Plowman GD, Culouscou JM, Whitney GS, et al. Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci USA 1993; 90: 1746–1750
   PubMed Web of Science ®Google Scholar
• Law AJ, Kleinman JE, Weinberger DR, Weickert CS. Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum Mol Genet 2007; 16: 129–141
   PubMed Web of Science ®Google Scholar
• Chong VZ, Thompson M, Beltaifa S, Webster MJ, Law AJ, Weickert CS. Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients. Schizophr Res 2008; 100: 270–280
   PubMed Web of Science ®Google Scholar
• Morita A, Yamashita N, Sasaki Y, et al. Regulation of dendritic branching and spine maturation by semaphorin3A-Fyn signaling. J Neurosci 2006; 26: 2971–2980
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Borkowska A, Skibinska M, Hauser J. Polymorphisms of the Fyn kinase gene and a performance on the Wisconsin Card Sorting Test in schizophrenia. Psychiatr Genet. 2007; 17: 201–204
   PubMed Web of Science ®Google Scholar
• Ishiguro H, Saito T, Shibuya H, Toru M, Arinami T. Mutation and association analysis of the Fyn kinase gene with alcoholism and schizophrenia. Am J Med Genet 2000; 96: 16–20
   Web of Science ®Google Scholar
• Dickerson J, Sharp FR. Atypical antipsychotics and a Src kinase inhibitor (PP1) prevent cortical injury produced by the psychomimetic, noncompetitive NMDA receptor antagonist MK-801. Neuropsychopharmacology 2006; 31: 1420–1430
   PubMed Web of Science ®Google Scholar
• Gemperle AY, Enz A, Pozza MF, Lüthi A, Olpe HR. Effects of clozapine, haloperidol, and iloperidone on neurotransmission and synaptic plasticity in prefrontal cortex and their accumulation in brain tissue: an in vitro study. Neuroscience 2003; 117: 681–695
   PubMed Web of Science ®Google Scholar
• Wittmann M, Marino MJ, Henze DA, Seabrook GR, Conn PJ. Clozapine potentiation of N-methyl-D-aspartate receptor currents in the nucleus accumbens: role of NR2B and protein kinase A/Src kinases. J Pharmacol Exp Ther 2005; 313: 594–603
   PubMed Web of Science ®Google Scholar
• Wang XD, Su YA, Guo CM, Yang Y, Si TM. Chronic antipsychotic drug administration alters the expression of neuregulin 1beta, ErbB2, ErbB3, and ErbB4 in the rat prefrontal cortex and hippocampus. Int J Neuropsychopharmacol 2008; 11: 553–5561
   PubMed Web of Science ®Google Scholar
• Shoham S, Javitt DC, Heresco-Levy U. Chronic high-dose glycine nutrition: effects on rat brain cell morphology. Biol Psychiatry 2001; 49: 876–885
   PubMed Web of Science ®Google Scholar
• Gray JA, Roth BL. Molecular targets for treating cognitive dysfunction in schizophrenia. Schizophr Bull 2007; 33: 1100–1119
   PubMed Web of Science ®Google Scholar
• Javitt DC, Duncan L, Balla A, Sershen H. Inhibition of system A-mediated glycine transport in cortical synaptosomes by the therapeutic concentrations of clozapine: implications for mechanisms of action. Mol Psychiatry 2005; 10: 275–287
   PubMed Web of Science ®Google Scholar
• Bennett MR. Stress and anxiety in schizophrenia and depression: glucocorticoids, corticotropin-releasing hormone and synapse regression. Aust N Z J Psychiatry 2008; 42: 995–1002
   PubMed Web of Science ®Google Scholar